Since VEGFC is known to have a selectivity towards lymphatic vessels [27], targeting of lymphangiogenesis seems to be a possible mechanism to explain the observed positive clinical effect of Artemisinin in rosacea. This evidence concerns the gene VEGFC and rosacea.